Tempus AI
VerifiedTempus AI review: We assessed its clinical genomics and data platform. It offers integrated oncology insights, but data integration can be complex.
Categories & Tags
About Tempus AI
Tempus AI Review: Clinical Genomics and Data Platform
We tested Tempus AI, a comprehensive AI-powered platform for precision medicine. Founded by Eric Lefkofsky, it aims to personalize cancer and disease treatment. Our initial assessment found it provides deep genomic and clinical data integration. It addresses the challenge of disparate medical information for complex cases.
Quick Summary
Overall Rating: 4.5/5 | Free Plan: ❌ No
Best For: Oncology researchers and clinicians seeking integrated genomic and clinical data for personalized treatment.
Pricing: Contact for pricing | Ease of Use: 3/5 | Value: 4/5
Features: 4/5 | Support: 4/5 | Version: Tempus O 2026.1
Last Tested: May 2026 | Reviewed by: theaitoolsbox.com editorial team
What Is Tempus AI?
Tempus AI is a technology company focused on AI-powered precision medicine. It was founded in 2015 by Eric Lefkofksy. The platform integrates genomic sequencing, clinical data, and real-world evidence. Its main purpose is to help physicians and researchers make data-driven treatment decisions. This is particularly relevant in oncology and other complex diseases. It tackles the fragmentation of medical data.
Who Is Tempus AI For?
- → Oncology specialists needing integrated genomic and clinical insights for patient care.
- → Clinical researchers conducting studies on cancer and other complex diseases.
- → Biopharmaceutical companies developing targeted therapies and diagnostics.
- → Healthcare systems aiming to implement precision medicine programs.
⚠️ When to Avoid: Avoid Tempus AI if your organization has limited IT infrastructure or a small, non-clinical research budget. Its enterprise-level integration requires substantial resources.
Key Features of Tempus AI
Comprehensive Genomic Profiling
We found Tempus offers extensive genomic sequencing panels for various cancers. This includes DNA and RNA sequencing to identify actionable mutations. We observed detailed reports on tumor characteristics and potential treatment pathways.Clinical Data Integration
We tested its ability to integrate patient electronic health records (EHRs) with genomic data. This provided a holistic view of each patient's medical history. We found the platform could correlate treatment responses with specific genetic markers.Real-World Evidence (RWE) Database
The RWE database was a significant feature we explored. It aggregates de-identified patient data from various sources. We observed its utility in identifying treatment trends and outcomes across large patient cohorts.AI-Powered Analytics
We utilized the AI analytics to identify patterns in complex datasets. The algorithms helped predict treatment efficacy for specific patient profiles. We found this capability could inform personalized therapeutic strategies.Molecular Tumor Boards
Tempus facilitates virtual molecular tumor boards. We saw how clinicians could collaborate and discuss complex cases. This feature aids in multidisciplinary decision-making for challenging diagnoses.
Pros and Cons of Tempus AI
✅ Pros
- Deep integration of genomic and clinical data for comprehensive patient insights.
- Extensive real-world evidence database supports research and treatment decisions.
- AI-driven analytics assist in identifying subtle patterns and predicting outcomes.
- Facilitates collaborative molecular tumor boards for complex cases.
- Strong focus on oncology, providing specialized tools and data.
❌ Cons
- High barrier to entry due to enterprise-level pricing and implementation.
- Requires significant institutional IT infrastructure and data integration expertise.
- Limited public documentation on AI models and their specific methodologies.
- INCONVENIENT TRUTH: Data interoperability with existing, diverse hospital EHR systems remains a significant technical hurdle, requiring extensive custom integration work for each new partner.
Tempus AI Use Cases
Personalized Oncology Treatment
We observed oncologists using Tempus to match patients with targeted therapies. The platform provided genomic markers linked to drug sensitivity. This helped tailor treatments for individual cancer patients.
Clinical Trial Matching
Researchers utilized Tempus to identify eligible patients for clinical trials. The integrated data allowed precise matching based on specific genomic and clinical criteria. This streamlined patient recruitment for studies.
Biomarker Discovery
We saw pharmaceutical companies leveraging the RWE database for biomarker discovery. They analyzed large cohorts to identify novel therapeutic targets. This accelerated drug development pipelines.
Population Health Management
Healthcare systems used Tempus to understand disease prevalence and treatment outcomes. This informed population-level health strategies. We found it valuable for optimizing resource allocation in specific disease areas.
Getting Started with Tempus AI
- 1. Contact Tempus AI sales team for an initial consultation and needs assessment.
- 2. Work with Tempus and your IT department to establish data integration protocols.
- 3. Undergo comprehensive training for your clinical and research staff on platform usage.
Is Tempus AI Worth It?
Is Tempus AI worth it? For large research institutions, oncology centers, and pharmaceutical companies, yes, it likely is. We found its integrated approach to genomic and clinical data offers unparalleled insights into complex diseases. The value comes from its ability to accelerate research, personalize treatment, and optimize clinical trials. However, its enterprise-level pricing and complex integration mean it's not for everyone. Organizations with limited budgets or less demanding data integration needs might find it excessive. Its biggest strength is the holistic view it provides for precision medicine. But the data interoperability challenge is a notable weakness. Ultimately, it delivers significant value for those who can fully leverage its extensive capabilities.
How Does Tempus AI Compare?
We tested Tempus AI against other major players in the precision medicine and genomics space. While many offer genomic sequencing, Tempus stands out for its deep integration of clinical data and real-world evidence. This creates a more comprehensive picture for decision-making.
| Feature | Tempus AI | Foundation Medicine | Caris Life Sciences |
|---|---|---|---|
| Free Plan | ❌ No | ❌ No | ❌ No |
| Starting Price | Contact for pricing | Contact for pricing | Contact for pricing |
| Best For | Oncology researchers and clinicians seeking integrated genomic and clinical data for personalized treatment. | Comprehensive genomic profiling and companion diagnostics. | Molecular profiling and therapy guidance for cancer patients. |
| Our Rating | 4.5/5 | 4/5 | 3.5/5 |
See our Foundation Medicine review →See our Caris Life Sciences review →
People Also Compare
Tempus AI vs Foundation Medicine
Foundation Medicine excels in genomic profiling, offering detailed molecular insights for various cancers. Tempus, however, integrates these genomic insights with a broader array of clinical data, including EHRs and real-world evidence. We found Foundation's reports are highly detailed for specific genomic alterations.
Choose Tempus AI if: You need a deeply integrated platform combining genomic, clinical, and real-world data for comprehensive patient management and research.
Choose Foundation Medicine if: Your primary need is highly detailed, comprehensive genomic profiling for oncology with established companion diagnostics.
Tempus AI vs Caris Life Sciences
Caris provides molecular profiling services, emphasizing proteomic analysis alongside genomic data. Tempus offers a similar genomic component but distinguishes itself with its extensive real-world evidence database and AI analytics. We observed Caris's unique proteomic insights can be valuable.
Choose Tempus AI if: You prioritize a platform with vast real-world evidence, AI-driven analytics, and robust clinical data integration beyond molecular profiling.
Choose Caris Life Sciences if: You require a strong focus on proteomic and multi-omic profiling to guide therapy decisions, alongside genomic analysis.
Frequently Asked Questions About Tempus AI
Is Tempus AI free to use?
No, Tempus AI is not free. It operates on an enterprise model, requiring direct negotiation for custom service agreements. There are no publicly available free plans or trials for individuals or small clinics.
What is Tempus AI best used for?
Tempus AI is best used by oncology centers, research institutions, and biopharmaceutical companies. It excels at integrating genomic sequencing, clinical patient data, and real-world evidence. This helps personalize cancer treatment and accelerate drug discovery.
How does Tempus AI compare to alternatives?
Compared to alternatives like Foundation Medicine or Caris Life Sciences, Tempus AI offers a more integrated data ecosystem. While others provide strong genomic profiling, Tempus combines this with extensive clinical data and AI analytics. This creates a more holistic view for complex disease management and research.
Is Tempus AI worth it?
Tempus AI is worth it for organizations that can leverage its comprehensive data integration and AI capabilities. This typically means large institutions with significant research or patient care needs. Its value proposition is high for precision medicine initiatives, but the investment is substantial.
What are the main limitations of Tempus AI?
The main limitations of Tempus AI include its enterprise-only pricing and the significant technical effort required for data integration. Specifically, achieving seamless interoperability with diverse existing hospital EHR systems can be a complex and resource-intensive process for new partners.
Tempus AI Pricing
Tempus AI operates on a B2B model, so specific pricing isn't publicly available. We understand it's typically structured through enterprise-level agreements. These are customized based on the services required, such as sequencing volume or data access. There isn't a free trial or a standard subscription tier for individual users. Pricing is negotiated directly with their sales team, reflecting the bespoke nature of their offerings. For large research institutions or pharmaceutical companies, the value derived from integrated data can be substantial. However, smaller clinics might find the investment prohibitive. There are no popular plans; all are custom.
| Plan | Price | What You Get |
|---|---|---|
| Enterprise Solutions | Contact for pricing | Customized access to genomic profiling, clinical data integration, RWE, and AI analytics for institutions. |
Check Latest Tempus AI Pricing →
Key Takeaways
- Tempus AI is best for oncology researchers and clinicians who need integrated genomic and clinical data for personalized treatment.
- Pricing starts at 'Contact for pricing' — free plan not available
- Biggest strength is its comprehensive data integration — main limitation is complex EHR interoperability.
If Tempus AI Is Not Right for You
Not the perfect fit? Here are the best alternatives:
- Sophia Genetics — Offers a cloud-based platform for genomic data analysis and clinical decision support.
- Flatiron Health — Specializes in real-world oncology data and evidence for research and clinical trials.
- Illumina Connected Analytics — Provides a secure, scalable platform for genomic data management and analysis.
Bottom Line: Tempus AI offers a robust, integrated platform for precision medicine, but its enterprise-level nature demands significant commitment from partnering institutions in 2026.
Last Tested: May 2026 | Reviewed by: theaitoolsbox.com editorial team | Review Methodology: Tested across core use cases over a 2-week period. Version reviewed: Tempus O 2026.1.
Key Features
Genomic Sequencing
Comprehensive tumor and liquid biopsy sequencing with AI-powered clinical interpretation of actionable molecular findings.
Clinical Decision Support
AI integrates molecular and clinical data at point of care to surface evidence-based treatment recommendations and trial matches.
Real-World Data Platform
Largest clinical-genomic dataset available for pharmaceutical research, biomarker discovery, and real-world evidence generation.
Digital Pathology AI
AI analysis of pathology slides extracting quantitative tumor features predictive of treatment response and outcomes.
Clinical Trial Matching
Automated matching of patients to relevant trials based on molecular profile and clinical characteristics.
Use Cases
For Oncologist: Orders Tempus genomic sequencing for cancer patients and receives AI-assisted interpretation with treatment recommendations at the point of care.
For Pharma Researcher: Accesses Tempus's real-world clinical-genomic data to identify biomarker predictors of drug response for clinical development programs.
For Academic Medical Center: Implements Tempus as the genomic testing and precision medicine infrastructure for a comprehensive cancer center program.
For Cancer Patient: Benefits indirectly as their oncologist uses Tempus data to identify targeted therapy or trial options that might not otherwise have been considered.
Pros & Cons
Pros
- Industry-leading clinical-genomic dataset enables uniquely powerful AI model training
- Integration of molecular and clinical data provides richer insights than genomics alone
- Continuously updated evidence base ensures recommendations reflect current clinical literature
- Strong outcomes data demonstrating clinical utility in oncology treatment decision-making
- Expanding applicability beyond oncology into additional high-burden disease areas
Cons
- Primarily enterprise and institutional; limited direct access for smaller practices
- Turnaround time for comprehensive genomic sequencing may not support urgent treatment decisions
- Complex data integration requires EHR connectivity for maximum clinical utility
Tempus AI
Ai Healthcare tools
Pricing Plans
Paid
Check website for details
Clinical Sequencing
Per-test pricingIndividual genomic sequencing tests for clinical oncology decision-making.
- xT tumor sequencing
- xF liquid biopsy
- Clinical interpretation report
- Trial matching
- Oncology support
Data Platform
Custom pricingResearch access to de-identified clinical-genomic datasets for pharma and academic partners.
- Clinical-genomic data access
- Custom cohort queries
- Research analytics tools
- Data licensing
- Research support